Physician

Mark F. Lierz, M.D.

According to 2025 Medicare claims, Mark Lierz, M.D. (NPI: 1497856702) practices urology in the St. Joseph, MO-KS market, with the plurality of this provider's patient population coming from Buchanan, MO. This provider's primary affiliated billing organization is PHOENIX UROLOGY OF ST. JOSEPH, INC. (NPI: 1679674048; TIN: 43-1597804) and primary practice location at 64506-6202.

Lierz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,669 traditional Medicare patients, billed 101,088 HCPCS/CPT codes, and received $1,500,620 in Medicare payments. The top billing code was 81007 (Urinalysis for bacteria). Part D data shows 5,984 prescription claims across 1,230 beneficiaries totaling $942,850 in drug costs, led by Xtandi (Enzalutamide). DME data shows 738 claims. Open Payments data shows 32 records totaling $548. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $769,124 to $1,500,620. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $388,801 and ending at $942,850. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,814	31,527	$769,124
2016	1,816	28,205	$690,311
2017	1,776	29,186	$697,154
2018	1,761	27,082	$690,002
2019	1,697	40,721	$617,115
2020	1,521	63,092	$591,173
2021	1,628	77,321	$1,175,772
2022	1,676	71,995	$976,561
2023	1,739	84,374	$1,371,134
2024	1,669	101,088	$1,500,620

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	948	5,700	$388,801
2016	996	5,993	$378,710
2017	1,013	5,761	$398,887
2018	997	5,521	$479,106
2019	939	5,036	$480,662
2020	912	4,780	$389,389
2021	926	4,666	$297,827
2022	1,012	5,033	$358,776
2023	1,138	5,463	$477,727
2024	1,230	5,984	$942,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	50	425	$91,946
2016	61	452	$72,641
2017	93	632	$91,529
2018	97	724	$144,982
2019	86	740	$167,162
2020	105	790	$191,124
2021	94	708	$193,461
2022	83	734	$207,742
2023	83	726	$228,505
2024	80	738	$247,604

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
81007	Urinalysis for bacteria	1,267	2,035	$29
82247	Bilirubin level, total	1,278	2,059	$5
83069	Urine hemoglobin level	1,278	2,059	$4
82945	Glucose (sugar) level on body fluid	1,274	2,045	$4
83986	Body fluid ph level	1,278	2,059	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	33	990	$445,501
Myrbetriq	Mirabegron	364	14,804	$224,431
Gemtesa	Vibegron	221	8,816	$142,302
Orgovyx	Relugolix	11	330	$27,731
Tamsulosin Hcl	Tamsulosin Hcl	1,140	80,820	$15,622

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	28	210	$180,516
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	33	256	$59,853
A4332	Lubricant, individual sterile packet, each	N	19	154	$1,826
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	15	$1,394
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	12	$1,326

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$548	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark F. Lierz, M.D.?

Tedicare shows public-source Medicare data for Mark F. Lierz, M.D. (NPI 1497856702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark F. Lierz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark F. Lierz, M.D.?

Mark F. Lierz, M.D. is linked to PHOENIX UROLOGY OF ST. JOSEPH, INC. (billing NPI 1679674048) in the available physician profile data.

Does Mark F. Lierz, M.D. have Open Payments data?

Mark F. Lierz, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.